Hormone Receptor-positive/Her2 Negative Breast Cancer trials recruiting in New Jersey

Fewer than 3 recruiting trials found.

All Hormone Receptor-positive/Her2 Negative Breast Cancer trials nationally

Cities in New Jersey

Recruiting trials in New Jersey

• Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
  NCT05579366 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Camden